VANCOUVER, Jan. 29 /CNW/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI,
TSX: ANP), a global specialty pharmaceutical and medical device company, is
scheduled to participate in the Merrill Lynch Global Pharmaceutical,
Biotechnology and Medical Device Conference, which is being held February 5-7
in New York, NY.
Dr. William Hunter, Angiotech's President and Chief Executive Officer, is
scheduled to present on Tuesday, February 5, at the Grand Hyatt New York,
beginning at approximately 3:20 pm ET. A Question and Answer period will
immediately follow the presentation.
A live audio-only webcast will be available to all interested parties on
the company's website, www.angiotech.com under the Investors section.
Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and
medical device company with over 1,500 dedicated employees. Angiotech
discovers, develops and markets innovative treatment solutions for diseases or
complications associated with medical device implants, surgical interventions
and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP),
please visit our website at www.angiotech.com.
For further information:
For further information: Deirdre Neary, Manager, Investor Relations,
Angiotech Pharmaceuticals, Inc., (604) 222-7056, firstname.lastname@example.org